Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$196M |
| 2 |
Verizon
VZ
|
+$166M |
| 3 |
Edison International
EIX
|
+$152M |
| 4 |
PPL
PPL Corp
PPL
|
+$122M |
| 5 |
Estee Lauder
EL
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameren
AEE
|
+$140M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$136M |
| 3 |
ANDV
Andeavor
ANDV
|
+$111M |
| 4 |
LyondellBasell Industries
LYB
|
+$105M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.77% |
| 2 | Energy | 13.48% |
| 3 | Utilities | 8.99% |
| 4 | Financials | 8.47% |
| 5 | Consumer Discretionary | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OA
876
DELISTED
Orbital ATK, Inc.
OA
| $8.9M | 0.03% |
62,644
+10,386
| +20% | +$1.39M |
|
877
lululemon athletica
LULU
$13.9B
| $8.88M | 0.03% |
168,838
-26,752
| -14% | -$1.33M |
|
|
TTPH
878
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $8.88M | 0.03% |
40,766
+27,301
| +203% | +$7.61M |
|
|
CONE
879
DELISTED
CyrusOne Inc Common Stock
CONE
| $8.87M | 0.03% |
+425,772
| New | +$9.27M |
|
880
Molina Healthcare
MOH
$10.4B
| $8.85M | 0.03% |
235,636
+20,091
| +9% | +$740K |
|
881
Navigator Holdings
NVGS
$1.37B
| $8.83M | 0.03% |
339,579
+48,843
| +17% | +$1.2M |
|
882
General Motors
GM
$76.3B
| $8.82M | 0.03% |
256,295
-584,128
| -70% | -$21.5M |
|
883
AerCap
AER
$23.2B
| $8.8M | 0.03% |
208,638
+144,963
| +228% | +$5.65M |
|
|
LSI
884
DELISTED
Life Storage, Inc.
LSI
| $8.79M | 0.03% |
179,550
+156,724
| +687% | +$7.31M |
|
885
Rigel Pharmaceuticals
RIGL
$843M
| $8.79M | 0.03% |
226,528
-101,827
| -31% | -$3.63M |
|
|
ALTR
886
DELISTED
Altera Corp
ALTR
| $8.72M | 0.03% |
240,638
-12,330
| -5% | -$423K |
|
|
AVNR
887
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $8.72M | 0.03% |
2,375,613
-263,142
| -10% | -$1M |
|
888
Loews
L
$22.8B
| $8.71M | 0.03% |
197,849
+167,306
| +548% | +$7.49M |
|
|
AZPN
889
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $8.71M | 0.03% |
205,698
+54,948
| +36% | +$2.33M |
|
890
Medifast
MED
$134M
| $8.69M | 0.03% |
298,772
-113,452
| -28% | -$3.04M |
|
891
VanEck Gold Miners ETF
GDX
$32.2B
| $8.68M | 0.03% |
367,620
+115,210
| +46% | +$2.83M |
|
892
PUT
Philip Morris
PM
$298B
| $8.63M | 0.03% |
105,400
+3,200
| +3% | +$259K |
|
|
OMG
893
DELISTED
OM GROUP INC.
OMG
| $8.62M | 0.03% |
259,357
+190,944
| +279% | +$6.4M |
|
894
PUT
Petrobras
PBR
$120B
| $8.58M | 0.02% |
652,500
-583,100
| -47% | -$6.81M |
|
895
CALL
Newmont
NEM
$139B
| $8.58M | 0.02% |
365,900
+307,200
| +523% | +$7.31M |
|
896
Dentsply Sirona
XRAY
$2.17B
| $8.56M | 0.02% |
185,899
-306,615
| -62% | -$14.2M |
|
|
ANAC
897
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $8.55M | 0.02% |
427,497
+91,943
| +27% | +$1.78M |
|
898
Alnylam Pharmaceuticals
ALNY
$31.6B
| $8.55M | 0.02% |
127,355
+121,944
| +2,254% | +$9.44M |
|
899
PUT
PVH
PVH
$3.55B
| $8.45M | 0.02% |
67,700
+16,100
| +31% | +$1.98M |
|
|
BGC
900
DELISTED
General Cable Corporation
BGC
| $8.45M | 0.02% |
329,813
+203,764
| +162% | +$5.9M |
|
Similar funds
Israel Englander's Q1 2014 Portfolio in Review
As of Q1 2014, Israel Englander held 4,356 positions worth $34.5B, up 8.9% from $31.7B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Israel Englander deployed $1.49B of net new capital in Q1 2014, opening 945 new positions and adding to 1,266 existing holdings. Its largest new stake was Bausch Health: 575,504 shares worth $75.9M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Energy and Utilities.
On the sell side, the largest reduction was Ameren, an estimated $140M trimmed.
- Israel Englander's largest Q1 2014 buy was Bausch Health: 575,504 shares worth $75.9M.
- Israel Englander added most to Devon Energy in Q1 2014, an estimated $196M increase.
- Israel Englander's biggest Q1 2014 reduction was Ameren, cutting an estimated $140M.
- Israel Englander fully exited PepsiCo in Q1 2014, selling an estimated $89.1M.
- Israel Englander's ten largest holdings make up 7.9% of its $34.5B portfolio in Q1 2014.
- Israel Englander opened 945 new positions and closed 958 in Q1 2014.
- Israel Englander's portfolio value rose 8.9% quarter-over-quarter to $34.5B.
Based on Millennium Management's 13F filing for Q1 2014, filed 15 May 2014.